Hesselink; Mayke B.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hesselink; Mayke B..The latest application filed is for "phenypiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition".

Company Profile

0.3.10

Hesselink; Mayke B. - Weep NL
Hesselink; Mayke B. - Weesp NL
Hesselink, Mayke B - Weesp NL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Phenylpiperazine derivatives with a combination of partial dopamine-D.sub.2 receptor agonism and serotonin reuptake inhibition Grant 8,101,619 - Feenstra , et al. January 24, 2	2012-01-24
N-oxides as prodrugs of piperazine and piperidine derivatives Grant 7,750,013 - Koopman , et al. July 6, 2	2010-07-06
Phenypiperazine Derivatives With A Combination Of Partial Dopamine-d2 Receptor Agonism And Serotonin Reuptake Inhibition App 20070142397 - Feenstra; Roelof W. ; et al.	2007-06-21
Diazabicyclo alkane derivatives with NK.sub.1 antagonistic activity Grant 7,202,238 - de Boer , et al. April 10, 2	2007-04-10
N-oxides as prodrugs of piperazine and piperidine derivatives App 20070043059 - Koopman; Theodorus S.M. ; et al.	2007-02-22
Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition App 20060247256 - Feenstra; Roelof W. ; et al.	2006-11-02
Aryloxyethylamine and phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition App 20060122247 - Feenstra; Roelof W. ; et al.	2006-06-08
Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition App 20060122190 - Feenstra; Roelof W. ; et al.	2006-06-08
Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition App 20060122189 - Feenstra; Roelof W. ; et al.	2006-06-08
Neurokinin-1 receptor antagonists for the treatment of conditions responsive to testosterone elevation, including testosterone deficiency App 20060030556 - Fuchs; Eberhard K.M. ; et al.	2006-02-09
1-[2H-1-benzopyran-2-one-8-yl]- piperazine derivatives for the treatment of movement disorders App 20050215551 - Bakker, Cornelis ; et al.	2005-09-29
1-[2H-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of pain App 20050215567 - Bakker, Cornelis ; et al.	2005-09-29
Diazabicyclo alkane derivatives with nk1 antagonistic activity App 20050119267 - Boer, Dirk de ; et al.	2005-06-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.